David Oldach

5.5k citations

86 papers · 4.2k indexed · 2 hit papers · h-index 29

Hepatology top 0.5%
- Hepatitis C virus research 15
Oceanography top 2%
- Marine and coastal ecosystems 11
Environmental Chemistry top 1%
- Marine Toxins and Detection Methods 18
Virology top 2%
Epidemiology top 1%
- Hepatitis B Virus Studies 12
- Pneumonia and Respiratory Infections 8
Ecology
- Microbial Community Ecology and Physiology 13
Molecular Biology
- Protist diversity and phylogeny 12
Infectious Diseases
- HIV/AIDS drug development and treatment 6

Co-authors: Robert Thimme Kyong‐Mi Chang Francis V. Chisari Stuart C. Ray Torstein Tengs Holly A. Bowers Diane K. Stoecker JoAnn M. Burkholder
Cited by: Hepatology Oceanography Environmental Chemistry
Journals: Journal of Hepatology (10 papers)Environmental Health Perspectives (7 papers)Clinical Infectious Diseases (5 papers)
Partner nations: United States France Germany

In The Last Decade

David Oldach

86 papers receiving 4.1k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2004 Proceedings of the National Academy of Sciences
2001 The Journal of Experimental Medicine

Peers

Countries citing papers authored by David Oldach

Since Specialization

Citations

This map shows the geographic impact of David Oldach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Oldach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Oldach more than expected).

Fields of papers citing papers by David Oldach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Oldach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Oldach. The network helps show where David Oldach may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David Oldach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Oldach Line = papers co-authored together David Oldach links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study Antiviral Research ·Susan Sloan,Kristy J. Szretter,Bharathi Sundaresh,Kristin Narayan,Patrick F. Smith,David Skurnik,Sylvain Bédard,José Trevejo,David Oldach,Zachary Shriver	2020	20
2	SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia Clinical Infectious Diseases ·Thomas M. File,Barbara Rewerska,友紀門倉,谭海仁,Anita Das,靖夫遠藤,David Taylor,Amanda Sheets,Prabhavathi Fernandes,David Oldach,Brian Jamieson	2016	58
3	A Randomized Study Evaluating Oral Fusidic Acid (CEM-102) in Combination With Oral Rifampin Compared With Standard-of-Care Antibiotics for Treatment of Prosthetic Joint Infections: A Newly Identified Drug–Drug Interaction Clinical Infectious Diseases ·J.G. Shields,Maria D. Iglesias-Ussel,靖夫遠藤,孝太岩田,Diane R. Mould,Richard Berkowitz,Cathleen Obray,Rabih O. Darouiche,David Oldach,Tarthang Tulku	2016	34
4	Solithromycin, a novel macrolide, does not prolong cardiac repolarization: a randomized, three-way crossover study in healthy subjects Journal of Antimicrobial Chemotherapy ·Börje Darpö,Philip T. Sager,Prabhavathi Fernandes,Brian Jamieson,靖夫遠藤,Meijian Zhou,David Oldach	2016	11
5	The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C Hepatology ·Stefan Zeuzem,Peter Buggisch,Kosh Agarwal,Patrick Marcellin,D. Séréni,Hartwig Klinker,Christophe Moreno,Jean‐Pierre Zarski,Yves Horsmans,Hongmei Mo,Sarah Arterburn,Steven Knox,David Oldach,John G. McHutchison,Michael P. Manns,Graham R. Foster	2011	94
6	273 SHORT TERM SAFETY, TOLERABILITY, PHARMACOKINETICS AND PRELIMINARY ACTIVITY OF GS-9450, A SELECTIVE CASPASE INHIBITOR, IN PATIENTS WITH CHRONIC HCV INFECTION Journal of Hepatology ·M.P. Manns,Eric Lawitz,A. I. M. Hoepelman,Hongjo Choi,R. D. B. Hudson,Melanie Cornpropst,Wen‐Chen Liang,Bernard D. King,Kenneth Hirsch,David Oldach,Franck Rousseau	2010	10
7	Tenofovir Is Effective Alone or With Emtricitabine in Adefovir-Treated Patients With Chronic-Hepatitis B Virus Infection Gastroenterology ·Thomas Berg,Patrick Marcellin,Fabien Zoulim,Bernd Möller,Huy N. Trinh,Sing Chan,Emilio Suárez,Fabien Lavocat,Andrea Snow‐Lampart,David Frederick,J. Sorbel,Katyna Borroto–Esoda,David Oldach,Franck Rousseau	2010	115
8	Occupational Exposure to Pfiesteria Species in Estuarine Waters Is Not a Risk Factor for Illness Environmental Health Perspectives ·J. Glenn Morris,Lynn M. Grattan,Leslie Wilson,Walter Meyer,Robert McCarter,Holly A. Bowers,J. Richard Hebel,Diane L. Matuszak,David Oldach	2006	8
9	Neutralizing antibody response during acute and chronic hepatitis C virus infectionbreakdown → Proceedings of the National Academy of Sciences ·Carine Logvinoff,Marian Major,David Oldach,Scott Heyward,Andrew H. Talal,Peter Balfe,S M Feinstone,Harrison Alter,Charles M. Rice,Jane A. McKeating	2004	332
10	Multidose jeopardy: HCV transmission risk and management of acute HCV in hospital settings Hepatology ·David Oldach	2002	6
11	Rhodococcus equi and cytomegalovirus pneumonia in a renal transplant patient: Diagnosis by fine-needle aspiration biopsy Diagnostic Cytopathology ·Aylin Simsir,David Oldach,Harshmani,Michael Henry	2001	14
12	Genetic polymorphism in Gymnodinium galatheanum chloroplast DNA sequences and development of a molecular detection assay Molecular Ecology ·Torstein Tengs,Holly A. Bowers,Andrew P. Ziman,Diane K. Stoecker,David Oldach	2001	34
13	GASTROINTESTINAL AND RESPIRATORY TRACT SYMPTOMS FOLLOWING BRIEF ENVIRONMENTAL EXPOSURE TO AEROSOLS DURING APFIESTERIA-RELATED FISH KILL Journal of Toxicology and Environmental Health ·Dirk Haselow,K. Thanabalasingam,J. Kathleen Tracy,Robert E. Magnien,Lynn M. Grattan,J. Glenn Morris,David Oldach	2001	15
14	Use of molecular probes to assess geographic distribution of Pfiesteria species. Environmental Health Perspectives ·Parke A. Rublee,Jason W. Kempton,李爱卿,Craig R. Allen,Yao Xiao-li,David Oldach,Zeyu Li,Torstein Tengs,JoAnn M. Burkholder,H Glasgow	2001	47
15	Cohort studies of health effects among people exposed to estuarine waters: North Carolina, Virginia, and Maryland. Environmental Health Perspectives ·Christine L. Moe,Elizabeth Turf,David Oldach,Malak Alsufayyan,S Makvandi-Nejad,David A. Savitz,(unknown),Megan Turf,Lily Ingsrisawang,Robert P. Hart,J. D. Ball,T.D. Zhang,Robert McCarter,L Wilson,Dirk Haselow,Lynn M. Grattan,J. Glenn Morris,Nel Nun	2001	21
16	Development of Real-Time PCR Assays for Rapid Detection of Pfiesteria piscicida and Related Dinoflagellates Applied and Environmental Microbiology ·Holly A. Bowers,Torstein Tengs,Howard B. Glasgow,JoAnn M. Burkholder,Parke A. Rublee,David Oldach	2000	197
17	Regarding Pfiesteria Human Organization ·David Oldach	1999	5
18	Community-Acquired Pneumonia: Impact of Immune Status American Journal of Respiratory and Critical Care Medicine ·Linda M. Mundy,Paul G. Auwaerter,David Oldach,M. L. Warner,Salima Atis,Estil Vance,Charlotte A. Gaydos,Jamie Joseph,R Gopalan,Richard D. Moore	1995	147
19	Diagnosis of Chlamydia pneumoniae Infection in Patients with Community-Acquired Pneumonia by Polymerase Chain Reaction Enzyme Immunoassay Clinical Infectious Diseases ·C A Gaydos,Joseph Eiden,David Oldach,Linda M. Mundy,Paul G. Auwaerter,M. L. Warner,Estil Vance,Salima Atis,Thomas C. Quinn	1994	54
20	Organs for transplantation. BMJ ·Stephen T. Bartlett,David Oldach,Stephen C. Schimpff	1989	1

About David Oldach

David Oldach is a scholar working on Hepatology, Environmental Chemistry and Oceanography, having authored 86 papers that have together received 4.2k indexed citations. Recurring topics across this work include Marine Toxins and Detection Methods (18 papers), Hepatitis C virus research (15 papers), Microbial Community Ecology and Physiology (13 papers), Protist diversity and phylogeny (12 papers), Hepatitis B Virus Studies (12 papers), Marine and coastal ecosystems (11 papers), Pneumonia and Respiratory Infections (8 papers) and HIV/AIDS drug development and treatment (6 papers). The work is most often cited by research in Hepatology (1.7k citations), Oceanography (769 citations) and Environmental Chemistry (615 citations). David Oldach has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Robert Thimme, Kyong‐Mi Chang, Francis V. Chisari, Stuart C. Ray, Torstein Tengs, Holly A. Bowers, Diane K. Stoecker, JoAnn M. Burkholder, Matthew D. Johnson and Parke A. Rublee. Their work appears in journals such as Journal of Hepatology, Environmental Health Perspectives, Clinical Infectious Diseases, Gastroenterology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact